首页 > 最新文献

Clinical Journal of the American Society of Nephrology最新文献

英文 中文
Effect of Remote and Virtual Technology on Home Dialysis. 远程和虚拟技术对家庭透析的影响。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-01-22 DOI: 10.2215/CJN.0000000000000405
Susie Q Lew, Sabrina Milan Manani, Claudio Ronco, Mitchell H Rosner, James A Sloand

In the United States, regulatory changes dictate telehealth activities. Telehealth was available to patients on home dialysis as early as 2019, allowing patients to opt for telehealth with home as the originating site and without geographic restriction. In 2020, coronavirus disease 2019 was an unexpected accelerant for telehealth use in the United States. Within nephrology, remote patient monitoring has most often been applied to the care of patients on home dialysis modalities. The effect that remote and virtual technologies have on home dialysis patients, telehealth and health care disparities, and health care providers' workflow changes are discussed here. Moreover, the future use of remote and virtual technologies to include artificial intelligence and artificial neural network model to optimize and personalize treatments will be highlighted. Despite these advances in technology challenges continue to exist, leaving room for future innovation to improve patient health outcome and equity. Prospective studies are needed to further understand the effect of using virtual technologies and remote monitoring on home dialysis outcomes, cost, and patient engagement.

在美国,监管变化决定了远程医疗活动。早在 2019 年,家庭透析患者就可以使用远程医疗,患者可以选择以家庭为出发点的远程医疗,不受地域限制。2020 年,COVID-19 意外地加速了远程医疗在美国的应用。在肾脏病学领域,远程患者监测最常应用于家庭透析患者的护理。本文讨论了远程和虚拟技术对家庭透析患者的影响、远程医疗和医疗保健差异以及医疗保健提供者工作流程的改变。此外,还将重点介绍远程和虚拟技术在未来的应用,包括人工智能和人工神经网络模型,以优化和个性化治疗。尽管技术取得了这些进步,但挑战依然存在,未来仍有创新的空间,以改善患者的健康结果和公平性。需要进行前瞻性研究,以进一步了解使用虚拟技术和远程监控对家庭透析效果、成本和患者参与度的影响。
{"title":"Effect of Remote and Virtual Technology on Home Dialysis.","authors":"Susie Q Lew, Sabrina Milan Manani, Claudio Ronco, Mitchell H Rosner, James A Sloand","doi":"10.2215/CJN.0000000000000405","DOIUrl":"10.2215/CJN.0000000000000405","url":null,"abstract":"<p><p>In the United States, regulatory changes dictate telehealth activities. Telehealth was available to patients on home dialysis as early as 2019, allowing patients to opt for telehealth with home as the originating site and without geographic restriction. In 2020, coronavirus disease 2019 was an unexpected accelerant for telehealth use in the United States. Within nephrology, remote patient monitoring has most often been applied to the care of patients on home dialysis modalities. The effect that remote and virtual technologies have on home dialysis patients, telehealth and health care disparities, and health care providers' workflow changes are discussed here. Moreover, the future use of remote and virtual technologies to include artificial intelligence and artificial neural network model to optimize and personalize treatments will be highlighted. Despite these advances in technology challenges continue to exist, leaving room for future innovation to improve patient health outcome and equity. Prospective studies are needed to further understand the effect of using virtual technologies and remote monitoring on home dialysis outcomes, cost, and patient engagement.</p>","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11469790/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension. 抗高血压药物治疗与血液透析中低血压的风险。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-16 DOI: 10.2215/CJN.0000000000000521
Carmine Zoccali, Giovanni Tripepi, Paola Carioni, Edouard L Fu, Friedo Dekker, Vianda Stel, Kitty J Jager, Francesca Mallamaci, Jeffrey L Hymes, Franklin W Maddux, Stefano Stuard
{"title":"Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension.","authors":"Carmine Zoccali, Giovanni Tripepi, Paola Carioni, Edouard L Fu, Friedo Dekker, Vianda Stel, Kitty J Jager, Francesca Mallamaci, Jeffrey L Hymes, Franklin W Maddux, Stefano Stuard","doi":"10.2215/CJN.0000000000000521","DOIUrl":"10.2215/CJN.0000000000000521","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11469783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study. 晚期慢性肾脏病老年患者的慢性肾脏病-糖尿病生物标志物与症状负担之间的关系:EQUAL 研究的结果。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-22 DOI: 10.2215/CJN.0000000000000510
Lorenza Magagnoli, Mario Cozzolino, Marie Evans, Fergus J Caskey, Friedo W Dekker, Claudia Torino, Maciej Szymczak, Christiane Drechsler, Maria Pippias, Antonio Vilasi, Roemer J Janse, Magdalena Krajewska, Vianda S Stel, Kitty J Jager, Nicholas C Chesnaye
{"title":"Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study.","authors":"Lorenza Magagnoli, Mario Cozzolino, Marie Evans, Fergus J Caskey, Friedo W Dekker, Claudia Torino, Maciej Szymczak, Christiane Drechsler, Maria Pippias, Antonio Vilasi, Roemer J Janse, Magdalena Krajewska, Vianda S Stel, Kitty J Jager, Nicholas C Chesnaye","doi":"10.2215/CJN.0000000000000510","DOIUrl":"10.2215/CJN.0000000000000510","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11469787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intradialytic Hypotension in the Face of Using Different Antihypertensive Medication Classes. 使用不同类别的降压药物时出现的椎管内低血压。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-09-04 DOI: 10.2215/CJN.0000000000000572
Csaba P Kovesdy
{"title":"Intradialytic Hypotension in the Face of Using Different Antihypertensive Medication Classes.","authors":"Csaba P Kovesdy","doi":"10.2215/CJN.0000000000000572","DOIUrl":"10.2215/CJN.0000000000000572","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11469771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diurnal and Daily Symptom Variation in Patients with ESKD. ESKD 患者的昼夜和日常症状变化。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 DOI: 10.2215/CJN.0000000000000573
Dawn P Edwards
{"title":"Diurnal and Daily Symptom Variation in Patients with ESKD.","authors":"Dawn P Edwards","doi":"10.2215/CJN.0000000000000573","DOIUrl":"https://doi.org/10.2215/CJN.0000000000000573","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11469763/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infection-Related GN with Cutaneous Vasculitis. 感染性肾小球肾炎伴皮肤血管炎
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-26 DOI: 10.2215/CJN.0000000000000503
Jodi Gedallovich, Ralph M Mohty, Ksenia Kasimova, Zhengchun Lu, Vivek Charu, John P Higgins, Neeraja Kambham, Vanderlene L Kung, Megan L Troxell
{"title":"Infection-Related GN with Cutaneous Vasculitis.","authors":"Jodi Gedallovich, Ralph M Mohty, Ksenia Kasimova, Zhengchun Lu, Vivek Charu, John P Higgins, Neeraja Kambham, Vanderlene L Kung, Megan L Troxell","doi":"10.2215/CJN.0000000000000503","DOIUrl":"10.2215/CJN.0000000000000503","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11469774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large Discordance between Creatinine-Based and Cystatin C-Based eGFRs is Associated with Falls, Hospitalizations, and Death in Older Adults. 基于肌酐的肾小球滤过率估算值与基于胱抑素 C 的肾小球滤过率估算值之间的巨大差异与老年人跌倒、住院和死亡有关。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-08-15 DOI: 10.2215/CJN.0000000000000523
Nurit Katz-Agranov, Meghan L Rieu-Werden, Ayush Thacker, Jacquelyn M Lykken, Meghan E Sise, Sachin J Shah
{"title":"Large Discordance between Creatinine-Based and Cystatin C-Based eGFRs is Associated with Falls, Hospitalizations, and Death in Older Adults.","authors":"Nurit Katz-Agranov, Meghan L Rieu-Werden, Ayush Thacker, Jacquelyn M Lykken, Meghan E Sise, Sachin J Shah","doi":"10.2215/CJN.0000000000000523","DOIUrl":"10.2215/CJN.0000000000000523","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11469786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141989436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Repeat Kidney Biopsies in Lupus Nephritis in a Largely Black and Hispanic Population. 在以黑人和西班牙裔为主的人群中,重复肾活检在狼疮性肾炎中的作用。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-30 DOI: 10.2215/CJN.0000000000000556
Anitha Ramu, Rosalba Santana de Roberts, Nang San Hti Lar Seng, Gopisree Peringeth, Hana Rajevac, James M Pullman, Meryl Waldman, Ladan Golestaneh, Belinda Jim
{"title":"The Role of Repeat Kidney Biopsies in Lupus Nephritis in a Largely Black and Hispanic Population.","authors":"Anitha Ramu, Rosalba Santana de Roberts, Nang San Hti Lar Seng, Gopisree Peringeth, Hana Rajevac, James M Pullman, Meryl Waldman, Ladan Golestaneh, Belinda Jim","doi":"10.2215/CJN.0000000000000556","DOIUrl":"https://doi.org/10.2215/CJN.0000000000000556","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Living donation and pregnancy complications: State of the evidence and ‘call-to-action’ for improved risk assessment 活体捐献与妊娠并发症:证据现状和改进风险评估的 "行动呼吁
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-20 DOI: 10.2215/cjn.0000000593
Ana P. Rossi, Goni Katz-Greenberg, Lisa Coscia, Carla W. Brady, Christina Doligalski, Roxanna A. Irani, Arthur Matas, Silvi Shah, Krista L. Lentine, Contraception and Pregnancy after Transplantation and Living Donation Controversies Conference Participants on behalf of the AST WHCOP Reproductive Health
of donation on future pregnancies as well as the impact of pregnancy complications on postdonation outcomes. In February of 2023, the American Society of Transplantation Women’s Health Community of Practice held a virtual Controversies Conference on reproductive health, contraception and pregnancy after transplantation and living donation. Experts in the field presented the available data. Smaller breakout sessions were created to discuss findings, identify knowledge gaps and develop recommendations. Herein we present the conference findings related to living donation. The evidence reviewed shows that gestational hypertension and gestational diabetes mellitus pre-kidney donation have been associated with an increased risk of developing postdonation hypertension and diabetes mellitus respectively, without increasing the risk of developing an estimated glomerular filtration rate <45 ml/min postdonation. The risk of preeclampsia in living kidney donors increases to 4-10% and low dose aspirin may help reduce that risk. Little is known about the financial burden of living donors that become pregnant, their risk of postpartum depression or the optimal time between donation and conception. The data on living liver donors is even scarcer. The creation of a registry of donor candidates may help answer many of these questions and in turn educate prospective donors so they can make an informed choice. Living kidney and liver donation significantly increase the organ supply to make lifesaving transplant possible, offering a survival advantage to the recipient and cost savings to the society. Of all living donors 40% are women of childbearing age. However limited data exist regarding the impact of donation on future pregnancies as well as the impact of pregnancy complications on postdonation outcomes. In February of 2023, the American Society of Transplantation Women’s Health Community of Practice held a virtual Controversies Conference on reproductive health, contraception and pregnancy after transplantation and living donation. Experts in the field presented the available data. Smaller breakout sessions were created to discuss findings, identify knowledge gaps and develop recommendations. Herein we present the conference findings related to living donation. The evidence reviewed shows that gestational hypertension and gestational diabetes mellitus pre-kidney donation have been associated with an increased risk of developing postdonation hypertension and diabetes mellitus respectively, without increasing the risk of developing an estimated glomerular filtration rate <45 ml/min postdonation. The risk of preeclampsia in living kidney donors increases to 4-10% and low dose aspirin may help reduce that risk. Little is known about the financial burden of living donors that become pregnant, their risk of postpartum depression or the optimal time between donation and conception. The data on living liver donors is even scarcer. The creation of a registry of donor ca
捐赠对未来妊娠的影响以及妊娠并发症对捐赠后结果的影响。2023 年 2 月,美国移植学会妇女健康实践社区就移植和活体捐献后的生殖健康、避孕和怀孕问题举行了一次虚拟争议会议。该领域的专家介绍了现有数据。会议设立了小型分组会议,以讨论研究结果、确定知识差距并提出建议。我们在此介绍与活体捐献相关的会议结果。审查的证据显示,肾脏捐献前的妊娠高血压和妊娠糖尿病分别与捐献后罹患高血压和糖尿病的风险增加有关,但不会增加捐献后估计肾小球滤过率<45毫升/分钟的风险。活体肾脏捐献者患先兆子痫的风险增加到 4-10%,小剂量阿司匹林可能有助于降低这一风险。人们对活体捐献者怀孕后的经济负担、产后抑郁的风险或捐献与受孕之间的最佳时间知之甚少。关于活体肝脏捐献者的数据更是少之又少。建立一个捐献者候选人登记册可能有助于回答其中的许多问题,进而教育潜在的捐献者,使他们能够做出明智的选择。活体肾脏和肝脏捐献大大增加了器官供应,使挽救生命的移植成为可能,为受捐者提供了生存优势,也为社会节约了成本。在所有活体捐献者中,40% 是育龄妇女。然而,有关捐献对未来怀孕的影响以及怀孕并发症对捐献后结果的影响的数据十分有限。2023 年 2 月,美国移植学会妇女健康实践社区就移植和活体捐献后的生殖健康、避孕和怀孕问题举行了一次虚拟争议会议。该领域的专家介绍了现有数据。会议设立了小型分组会议,以讨论研究结果、确定知识差距并提出建议。我们在此介绍与活体捐献相关的会议结果。审查的证据显示,肾脏捐献前的妊娠高血压和妊娠糖尿病分别与捐献后罹患高血压和糖尿病的风险增加有关,但不会增加捐献后估计肾小球滤过率<45毫升/分钟的风险。活体肾脏捐献者患先兆子痫的风险增加到 4-10%,小剂量阿司匹林可能有助于降低这一风险。人们对活体捐献者怀孕后的经济负担、产后抑郁的风险或捐献与受孕之间的最佳时间知之甚少。关于活体肝脏捐献者的数据更是少之又少。建立捐献者候选者登记册可能有助于回答其中的许多问题,进而教育潜在的捐献者,使他们能够做出明智的选择。版权所有 © 2024 年美国肾脏病学会...
{"title":"Living donation and pregnancy complications: State of the evidence and ‘call-to-action’ for improved risk assessment","authors":"Ana P. Rossi, Goni Katz-Greenberg, Lisa Coscia, Carla W. Brady, Christina Doligalski, Roxanna A. Irani, Arthur Matas, Silvi Shah, Krista L. Lentine, Contraception and Pregnancy after Transplantation and Living Donation Controversies Conference Participants on behalf of the AST WHCOP Reproductive Health","doi":"10.2215/cjn.0000000593","DOIUrl":"https://doi.org/10.2215/cjn.0000000593","url":null,"abstract":"of donation on future pregnancies as well as the impact of pregnancy complications on postdonation outcomes. In February of 2023, the American Society of Transplantation Women’s Health Community of Practice held a virtual Controversies Conference on reproductive health, contraception and pregnancy after transplantation and living donation. Experts in the field presented the available data. Smaller breakout sessions were created to discuss findings, identify knowledge gaps and develop recommendations. Herein we present the conference findings related to living donation. The evidence reviewed shows that gestational hypertension and gestational diabetes mellitus pre-kidney donation have been associated with an increased risk of developing postdonation hypertension and diabetes mellitus respectively, without increasing the risk of developing an estimated glomerular filtration rate &lt;45 ml/min postdonation. The risk of preeclampsia in living kidney donors increases to 4-10% and low dose aspirin may help reduce that risk. Little is known about the financial burden of living donors that become pregnant, their risk of postpartum depression or the optimal time between donation and conception. The data on living liver donors is even scarcer. The creation of a registry of donor candidates may help answer many of these questions and in turn educate prospective donors so they can make an informed choice. Living kidney and liver donation significantly increase the organ supply to make lifesaving transplant possible, offering a survival advantage to the recipient and cost savings to the society. Of all living donors 40% are women of childbearing age. However limited data exist regarding the impact of donation on future pregnancies as well as the impact of pregnancy complications on postdonation outcomes. In February of 2023, the American Society of Transplantation Women’s Health Community of Practice held a virtual Controversies Conference on reproductive health, contraception and pregnancy after transplantation and living donation. Experts in the field presented the available data. Smaller breakout sessions were created to discuss findings, identify knowledge gaps and develop recommendations. Herein we present the conference findings related to living donation. The evidence reviewed shows that gestational hypertension and gestational diabetes mellitus pre-kidney donation have been associated with an increased risk of developing postdonation hypertension and diabetes mellitus respectively, without increasing the risk of developing an estimated glomerular filtration rate &lt;45 ml/min postdonation. The risk of preeclampsia in living kidney donors increases to 4-10% and low dose aspirin may help reduce that risk. Little is known about the financial burden of living donors that become pregnant, their risk of postpartum depression or the optimal time between donation and conception. The data on living liver donors is even scarcer. The creation of a registry of donor ca","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142321554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication Burden and Adverse Cardiovascular Events and Death in Patients Treated with Maintenance Hemodialysis: A Nationwide Cohort Study 维持性血液透析患者的用药负担与不良心血管事件和死亡:一项全国性队列研究
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-20 DOI: 10.2215/cjn.0000000000000570
Cheol Ho Park, Ye Eun Ko, Ga Young Heo, Bo Yeon Kim, Seong Ju Oh, So Young Han, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Hyung Woo Kim
ied to investigate the prognostic implications of medication burden regarding adverse outcomes in patients with end-stage kidney disease with maintenance hemodialysis. Methods We analyzed 26,690 patients receiving maintenance hemodialysis who participated in the Periodic Hemodialysis Quality Assessment conducted by the Health Insurance Review and Assessment Service. The exposure of interest was the number of routinely prescribed oral medications. The main outcome was a composite of non-fatal cardiovascular events (non-fatal myocardial infarction, coronary revascularization, non-fatal stroke, or hospitalization for heart failure) or all-cause death (major adverse cardiac and cerebrovascular events). The secondary outcomes were the individual components of the primary outcome. Results During a follow-up period of 146,749 person-years (median, 6.0 years), major adverse cardiac and cerebrovascular events occurred in 17,573 (59.2%) patients. Higher medication burden was associated with progressively higher incidence of major adverse cardiac and cerebrovascular events (84.7, 107.2, 130.2, and 168.9 events per 1000 person-years in Q1–Q4, respectively). In a multivariable Cox proportional hazard model, the adjusted hazard ratios (95% confidence intervals) for the second, third, and highest quartiles were 1.05 (1.00–1.10), 1.12 (1.07–1.17), and 1.27 (1.21–1.33), respectively, compared with the lowest quartile. In continuous modeling, each increase in the number of medication was associated with a 1.03-fold (95% confidence interval 1.03–1.04) higher risk of the primary outcome. Conclusion A high medication burden was independently associated with higher risk of adverse cardiovascular outcomes and all-cause death in patients receiving maintenance hemodialysis. These findings suggest that a high medication burden could be a useful indicator of adverse clinical outcomes in patients undergoing hemodialysis. Copyright © 2024 by the American Society of Nephrology...
目的:研究药物负担对接受维持性血液透析的终末期肾病患者不良预后的影响。方法 我们对 26,690 名接受维持性血液透析的患者进行了分析,这些患者参加了由健康保险审查和评估服务机构进行的定期血液透析质量评估。我们关注的暴露是常规处方口服药物的数量。主要结果是非致死性心血管事件(非致死性心肌梗死、冠状动脉血运重建、非致死性中风或因心力衰竭住院)或全因死亡(主要不良心脑血管事件)的复合结果。次要结果是主要结果的各个组成部分。结果 在 146,749 人年(中位数为 6.0 年)的随访期间,17,573 名患者(59.2%)发生了重大心脏和脑血管不良事件。用药负担越重,重大心脏和脑血管不良事件的发生率越高(在第一季度至第四季度,每千人年分别为 84.7、107.2、130.2 和 168.9 例)。在多变量考克斯比例危险模型中,与最低四分位数相比,第二、第三和最高四分位数的调整危险比(95% 置信区间)分别为 1.05(1.00-1.10)、1.12(1.07-1.17)和 1.27(1.21-1.33)。在连续模型中,药物数量每增加一种,主要结果的风险就增加 1.03 倍(95% 置信区间 1.03-1.04)。结论 在接受维持性血液透析的患者中,药物负担过重与不良心血管后果和全因死亡的风险较高密切相关。这些研究结果表明,高药物负担可能是血液透析患者不良临床结局的一个有用指标。版权所有 © 2024 年美国肾脏病学会...
{"title":"Medication Burden and Adverse Cardiovascular Events and Death in Patients Treated with Maintenance Hemodialysis: A Nationwide Cohort Study","authors":"Cheol Ho Park, Ye Eun Ko, Ga Young Heo, Bo Yeon Kim, Seong Ju Oh, So Young Han, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Hyung Woo Kim","doi":"10.2215/cjn.0000000000000570","DOIUrl":"https://doi.org/10.2215/cjn.0000000000000570","url":null,"abstract":"ied to investigate the prognostic implications of medication burden regarding adverse outcomes in patients with end-stage kidney disease with maintenance hemodialysis. Methods We analyzed 26,690 patients receiving maintenance hemodialysis who participated in the Periodic Hemodialysis Quality Assessment conducted by the Health Insurance Review and Assessment Service. The exposure of interest was the number of routinely prescribed oral medications. The main outcome was a composite of non-fatal cardiovascular events (non-fatal myocardial infarction, coronary revascularization, non-fatal stroke, or hospitalization for heart failure) or all-cause death (major adverse cardiac and cerebrovascular events). The secondary outcomes were the individual components of the primary outcome. Results During a follow-up period of 146,749 person-years (median, 6.0 years), major adverse cardiac and cerebrovascular events occurred in 17,573 (59.2%) patients. Higher medication burden was associated with progressively higher incidence of major adverse cardiac and cerebrovascular events (84.7, 107.2, 130.2, and 168.9 events per 1000 person-years in Q1–Q4, respectively). In a multivariable Cox proportional hazard model, the adjusted hazard ratios (95% confidence intervals) for the second, third, and highest quartiles were 1.05 (1.00–1.10), 1.12 (1.07–1.17), and 1.27 (1.21–1.33), respectively, compared with the lowest quartile. In continuous modeling, each increase in the number of medication was associated with a 1.03-fold (95% confidence interval 1.03–1.04) higher risk of the primary outcome. Conclusion A high medication burden was independently associated with higher risk of adverse cardiovascular outcomes and all-cause death in patients receiving maintenance hemodialysis. These findings suggest that a high medication burden could be a useful indicator of adverse clinical outcomes in patients undergoing hemodialysis. Copyright © 2024 by the American Society of Nephrology...","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142321555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Journal of the American Society of Nephrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1